StockClub

TEVJF

TEVJFTeva Pharmaceutical Industries Limited$ --
Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited

TEVJF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
4,808M USD
YoY +13.7%
Operating Income
1,294M USD
YoY +4562.6%
Net Income
490M USD
YoY +325.8%
EPS
0.43$
YoY +326.3%

Revenue

$17.4B
FY2024 Q1$3.8B
$3.8B
Q1
FY2024 Q2$8B
$8B
Q2
FY2024 Q3$12.3B
$12.3B
Q3
FY2024 Q4$16.5B
$16.5B
Q4
FY2025 Q1$3.9B
$3.9B
Q1
FY2025 Q2$8.1B
$8.1B
Q2
FY2025 Q3$12.5B
$12.5B
Q3
FY2025 Q4$17.4B
$17.4B
Q4
Actual
+$812.1M (+4.9%)

Net Income

$1.4B
FY2024 Q1$-139M
$-139M
Q1
FY2024 Q2$-985M
$-985M
Q2
FY2024 Q3$-1.4B
$-1.4B
Q3
FY2024 Q4$-1.6B
$-1.6B
Q4
FY2025 Q1$214M
$214M
Q1
FY2025 Q2$496M
$496M
Q2
FY2025 Q3$929M
$929M
Q3
FY2025 Q4$1.4B
$1.4B
Q4
Actual
+$3.1B (+186.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$16.7B
Est:$17B
FY2020MISS
$16.7B
FY2021MISS
Actual:$15.9B
Est:$16.4B
FY2021MISS
$15.9B
FY2022BEAT
Actual:$14.9B
Est:$14.7B
FY2022BEAT
$14.9B
FY2023MISS
Actual:$15.8B
Est:$15.8B
FY2023MISS
$15.8B
FY2024BEAT
Actual:$16.5B
Est:$16.3B
FY2024BEAT
$16.5B
FY2025BEAT
Actual:$18.7B
Est:$16.7B
FY2025BEAT
$18.7B

Analyst Estimates